Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates

Targeted tumour therapy has proved to be an efficient alternative to overcome the limitations of conventional chemotherapy. Among several receptors upregulated in cancer cells, the gastrin-releasing peptide receptor (GRP-R) has recently emerged as a promising target for cancer imaging, diagnosing an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomena, Jacopo, Vári, Balázs, Oláh-Szabó, Rita, Biri-Kovács, Beáta, Bősze, Szilvia, Borbély, Adina, Soós, Ádám, Ranđelović, Ivan, Tóvári, József, Mező, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967152/
https://www.ncbi.nlm.nih.gov/pubmed/36834815
http://dx.doi.org/10.3390/ijms24043400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967152/
https://www.ncbi.nlm.nih.gov/pubmed/36834815
http://dx.doi.org/10.3390/ijms24043400

Ejemplares similares